Which has the lower trailing P/E, MRK or RHHBY?

RHHBY has the lower trailing P/E: MRK trades at 122.48 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MRK or RHHBY?

Over the past five years, MRK grew revenue faster — MRK at a 7.87% CAGR versus RHHBY at 3.94%.

Does MRK or RHHBY pay a bigger dividend?

MRK yields 2.19% and RHHBY yields 2.75% based on trailing dividends and the latest price.

Is MRK or RHHBY more profitable?

RHHBY runs the higher net margin — MRK at 4.78% versus RHHBY at 20.33%.

How have MRK and RHHBY total returns compared?

Over the past 10 years, MRK delivered 13.26% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.

Merck & Co., Inc. (MRK) vs Roche Holding AG (RHHBY)

A side-by-side comparison of Merck & Co., Inc. and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.

MRK

Merck & Co., Inc.

$369.34B

$149.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

RHHBY

Roche Holding AG

$359.46B

$56.39HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — MRK vs RHHBY

growth of $100 · dividends reinvested · last 10y

MRK +247.9% (+13.3%/yr)RHHBY +146.1% (+9.4%/yr)MRK compounded faster over this window

MRK RHHBY

MRK vs RHHBY: by the numbers

•MRK is the larger company ($369.34B vs $359.46B market cap).
•RHHBY trades at the lower trailing earnings multiple (16.15 vs 122.48 P/E), one valuation lens rather than an overall verdict.
•RHHBY converts more revenue to profit (20.33% vs 4.78% net margin).
•MRK grew revenue faster over the past five years (7.87% vs 3.94% CAGR).
•RHHBY pays the higher dividend yield (2.75% vs 2.19%).

Metrics side by side

Valuation

Metric	MRK	RHHBY
P/E ratio	122.48	16.15
Forward P/E	55.70	22.83
P/S ratio	5.70	4.53
P/B ratio	9.03	9.06
EV / EBITDA	24.06	14.21
FCF yield	4.24%	4.69%

Profitability

Metric	MRK	RHHBY
Gross margin	75.38%	73.73%
Operating margin	36.17%	29.16%
Net margin	4.78%	20.33%
ROE	7.57%	38.06%
ROIC	5.80%	19.71%

Dividends

Metric	MRK	RHHBY
Dividend yield	2.19%	2.75%
Payout ratio	46.03%	60.81%

Growth (annualized)

Metric	MRK	RHHBY
Revenue CAGR (5Y)	7.87%	3.94%
EPS CAGR (5Y)	21.21%	1.54%
FCF CAGR (5Y)	23.61%	5.54%
Total return CAGR (5Y)	18.50%	5.84%

Frequently asked

Which has the lower trailing P/E, MRK or RHHBY?: RHHBY has the lower trailing P/E: MRK trades at 122.48 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MRK or RHHBY?: Over the past five years, MRK grew revenue faster — MRK at a 7.87% CAGR versus RHHBY at 3.94%.
Does MRK or RHHBY pay a bigger dividend?: MRK yields 2.19% and RHHBY yields 2.75% based on trailing dividends and the latest price.
Is MRK or RHHBY more profitable?: RHHBY runs the higher net margin — MRK at 4.78% versus RHHBY at 20.33%.
How have MRK and RHHBY total returns compared?: Over the past 10 years, MRK delivered 13.26% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRK analysis Full RHHBY analysis Interactive comparison tool

Dig into the metrics

Merck P/E ratio Roche Holding AG P/E ratio Merck dividend yield Roche Holding AG dividend yield Merck ROE Roche Holding AG ROE Merck operating margin Roche Holding AG operating margin Merck revenue growth Roche Holding AG revenue growth Merck free cash flow Roche Holding AG free cash flow

Merck & Roche Holding AG appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.